INS and type 2 diabetes mellitus: Experimental studies in rodents and humans have shown that impaired MC4R signaling increases insulin secretion (Fan et al., 2000, Greenfield et al., 2009), which may affect the onset and prevalence of type 2 diabetes in variant carriers through mechanisms that require further exploration.